Alain Bélanger spends much of his time researching Internal medicine, Endocrinology, Androgen, Dehydroepiandrosterone and Dihydrotestosterone. Internal medicine is closely attributed to Glucuronidation in his study. His Glucuronidation research is multidisciplinary, relying on both Glucuronosyltransferase and Steroid.
His work in Testosterone, Menopause, Estrogen, Estrone and Hormone is related to Endocrinology. In his work, Pituitary gland is strongly intertwined with Androgen receptor, which is a subfield of Androgen. His Dehydroepiandrosterone research incorporates themes from Sex hormone-binding globulin, NADP metabolism, Dehydroepiandrosterone sulfate and Raloxifene.
His primary areas of investigation include Internal medicine, Endocrinology, Androgen, Testosterone and Dehydroepiandrosterone. Internal medicine is represented through his Antiandrogen, Flutamide, Prostate cancer, Estrogen and Prostate research. His biological study spans a wide range of topics, including Glucuronidation and Androgen receptor.
His studies in Testosterone integrate themes in fields like Steroid hormone and Prolactin. His work deals with themes such as Menopause, Lipoprotein and Dehydroepiandrosterone sulfate, which intersect with Dehydroepiandrosterone. The study incorporates disciplines such as Androsterone and LNCaP in addition to Dihydrotestosterone.
Alain Bélanger mostly deals with Internal medicine, Endocrinology, Androgen, Glucuronidation and Dihydrotestosterone. His Internal medicine study frequently intersects with other fields, such as Glucuronosyltransferase. His study in Dehydroepiandrosterone, Testosterone, Estrogen, Estrone and Androsterone glucuronide is carried out as part of his studies in Endocrinology.
The Dehydroepiandrosterone study combines topics in areas such as Metencephalon, Adrenal cortex, Pregnenolone and Cytochrome P450. The concepts of his Androgen study are interwoven with issues in Androsterone, Cancer, LNCaP and Androgen receptor. His Glucuronidation research also works with subjects such as
Alain Bélanger mainly investigates Internal medicine, Endocrinology, Dehydroepiandrosterone, Androgen and Glucuronidation. His study in Prostate, Prostate cancer, Metabolite, Endometrium and Steroid hormone falls within the category of Internal medicine. Endocrinology is frequently linked to Hormone replacement therapy in his study.
His study in Dehydroepiandrosterone is interdisciplinary in nature, drawing from both Cholesterol side-chain cleavage enzyme, Pregnenolone and Theca interna. His Glucuronidation research includes themes of Cell, Subcellular localization, Sequence analysis and Cell growth. As part of the same scientific family, he usually focuses on Dihydrotestosterone, concentrating on Steroid and intersecting with UGT2B4, Peptide secretion and Peptide hormone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.
Peter I. Mackenzie;Ida S. Owens;Brian Burchell;K. W. Bock.
Pharmacogenetics (1997)
Marked Decline in Serum Concentrations of Adrenal C19 Sex Steroid Precursors and Conjugated Androgen Metabolites During Aging
Fernand Labrie;Alain Bélanger;Lionel Cusan;José-Luis Gomez.
The Journal of Clinical Endocrinology and Metabolism (1997)
Is dehydroepiandrosterone a hormone
F Labrie;V Luu-The;A Bélanger;S-X Lin.
Journal of Endocrinology (2005)
Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology
Fernand Labrie;Alain Bélanger;Lionel Cusan;Bernard Candas.
The Journal of Clinical Endocrinology and Metabolism (1997)
Endocrine and intracrine sources of androgens in women: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone
Fernand Labrie;Van Luu-The;Claude Labrie;Alain Bélanger.
Endocrine Reviews (2003)
DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging
Fernand Labrie;Alain Bélanger;Van Luu-The;Claude Labrie.
Steroids (1998)
Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.
Fernand Labrie;Bernard Candas;André Dupont;Lionel Cusan.
The Prostate (1999)
The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Fernand Labrie;Van Luu-The;Sheng-Xiang Lin;Labrie Claude.
Steroids (1997)
Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
David Turgeon;Jean-Sébastien Carrier;Éric Lévesque;Dean W. Hum.
Endocrinology (2001)
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.
Fernand Labrie;Pierre Diamond;Leonello Cusan;Jose-Luis Gomez.
The Journal of Clinical Endocrinology and Metabolism (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Laval
Université Laval
Université Laval
Université Laval
Université Laval
University of Iowa
Shriners Hospitals for Children - Erie
University of Rouen
McGill University
University of Rouen
Stony Brook University
University of Granada
Institute of Labor Economics
IBM (United States)
IBM (United States)
Exium
Ningbo University
University of Hyderabad
Kansas State University
Sun Yat-sen University
Northwestern University
Bristol Myers Squibb
University of Zurich
University of Southern California
Maastricht University
Kyushu University